1069 related articles for article (PubMed ID: 25560712)
21. External validation of the DASH prediction rule: a retrospective cohort study.
Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
[TBL] [Abstract][Full Text] [Related]
22. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism.
Bauer KA
JAMA; 2011 Apr; 305(13):1336-45. PubMed ID: 21386068
[TBL] [Abstract][Full Text] [Related]
23. D-dimer testing to determine the duration of anticoagulation therapy.
Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
[TBL] [Abstract][Full Text] [Related]
24. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
Prandoni P; Milan M; Sarolo L; Zanon E; Bilora F
Int Angiol; 2017 Oct; 36(5):395-401. PubMed ID: 27982558
[TBL] [Abstract][Full Text] [Related]
25. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
26. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
27. D-dimer levels and risk of recurrent venous thromboembolism.
Eichinger S; Minar E; Bialonczyk C; Hirschl M; Quehenberger P; Schneider B; Weltermann A; Wagner O; Kyrle PA
JAMA; 2003 Aug; 290(8):1071-4. PubMed ID: 12941680
[TBL] [Abstract][Full Text] [Related]
28. D-dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model.
Eichinger S; Heinze G; Kyrle PA
J Am Heart Assoc; 2014 Jan; 3(1):e000467. PubMed ID: 24385451
[TBL] [Abstract][Full Text] [Related]
29. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of D-Dimer Testing in Predicting Recurrence in Elderly Patients with Unprovoked Venous Thromboembolism.
Tritschler T; Limacher A; Méan M; Rodondi N; Aujesky D
Am J Med; 2017 Oct; 130(10):1221-1224. PubMed ID: 28522384
[TBL] [Abstract][Full Text] [Related]
31. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
[TBL] [Abstract][Full Text] [Related]
32. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
[TBL] [Abstract][Full Text] [Related]
33. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
[TBL] [Abstract][Full Text] [Related]
34. [The optimal duration of anticoagulant treatment following pulmonary embolism].
Couturaud F
Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
[TBL] [Abstract][Full Text] [Related]
35. D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.
Kearon C; Stevens SM; Julian JA
Ann Intern Med; 2015 May; 162(9):671. PubMed ID: 25939006
[No Abstract] [Full Text] [Related]
36. D-Dimer Testing in Patients With a First Unprovoked Venous Thromboembolism.
Palareti G
Ann Intern Med; 2015 May; 162(9):670-1. PubMed ID: 25939005
[No Abstract] [Full Text] [Related]
37. Impact and clinical significance of recurrent venous thromboembolism.
Labropoulos N; Spentzouris G; Gasparis AP; Meissner M
Br J Surg; 2010 Jul; 97(7):989-99. PubMed ID: 20632262
[TBL] [Abstract][Full Text] [Related]
38. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409
[TBL] [Abstract][Full Text] [Related]
39. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study.
Xu Y; Khan F; Kovacs MJ; Sabri E; Carrier M; Righini M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Crowther MA; White RH; Rodger M; Le Gal G
Thromb Res; 2023 Nov; 231():32-38. PubMed ID: 37801772
[TBL] [Abstract][Full Text] [Related]
40. D-dimer before chemotherapy might predict venous thromboembolism.
Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
